Partners in Financial Planning’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$331K Hold
1,317
– – 0.05% 100
2026
Q1
$286K Hold
1,317
– – 0.05% 106
2025
Q4
$301K Buy
1,317
+1
+0.1% +$228 0.05% 97
2025
Q3
$305K Hold
1,316
– – 0.05% 93
2025
Q2
$244K Hold
1,316
– – 0.05% 99
2025
Q1
$276K Hold
1,316
– – 0.06% 89
2024
Q4
$234K Hold
1,316
– – 0.05% 97
2024
Q3
$260K Buy
1,316
+88
+7% +$16.4K 0.05% 93
2024
Q2
$211K Hold
1,228
– – 0.05% 103
2024
Q1
$224K Buy
+1,228
New +$212K 0.05% 97

Other funds holding ABBV

Partners in Financial Planning's ABBV Position: Q2 2026 in Review

Partners in Financial Planning held its AbbVie (ABBV) position steady in Q2 2026 at 1,317 shares worth $331K. The position accounts for 0.05% of the portfolio, ranked #100.

Partners in Financial Planning first reported a position in ABBV in Q1 2024 and has held it in 10 quarters since. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Partners in Financial Planning held 1,317 shares of AbbVie worth $331K as of Q2 2026.
  • Partners in Financial Planning left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.05% of Partners in Financial Planning's portfolio in Q2 2026, its #100 holding.
  • Partners in Financial Planning first reported a position in AbbVie in Q1 2024 and has held it in 10 quarters since.
  • 4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Partners in Financial Planning's 13F filing for Q2 2026, filed 10 Aug 2026.